Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label attachment file name title previous answer version answering member constituency answering member printed answering member
tabling member	label

Search

1546980

registered interest
date	30/11/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pneumococcal Diseases: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, If he will take steps to ensure that NHS England prioritises the uptake of pneumococcal vaccinations.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	99847
answer	answer is ministerial correction date of answer 09/12/2022 answer text <p>To improve the uptake across the pneumococcal programmes, vaccinations are offered all year round and general practitioners (GPs) proactively invite patients when they are eligible.</p><p>For the adult programme, this applies to those aged 65 years old and over and in the childhood programme, this applies to children aged 12 weeks, one year old and clinical risk groups at two years old and over. All parents are also actively encouraged to check their children’s vaccine records and contact their local GP if they have missed any vaccinations.</p> answering member constituency Harborough answering member printed Neil O'Brien question first answered 09/12/2022 12:48:26 answering member 4679 label Biography information for Neil O'Brien
tabling member	4131 label Biography information for Jim Shannon

1544970

registered interest
date	23/11/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pneumococcal Diseases: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to ensure high levels of uptake of pneumococcal vaccinations ahead of winter 2022-23.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	94750
answer	answer is ministerial correction date of answer 30/11/2022 answer text <p>As the pneumococcal programmes are not seasonal, General practitioners contact patients throughout the year as they reach the eligible age. For the adult programme, this applies to those aged 65 year old and over and in the childhood programme, this applies to children aged 12 weeks, one year old and clinical risk groups at two years old and over.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 30/11/2022 10:37:06 answering member 4492 label Biography information for Maria Caulfield
tabling member	4131 label Biography information for Jim Shannon

1403472

registered interest
date	17/01/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pneumococcal Diseases: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if the forthcoming All Vaccines Strategy will set a target of 75% for adult pneumococcal vaccination coverage in line with coverage targets set for influenza vaccination.
tabling member constituency	Wimbledon
tabling member printed	Stephen Hammond
uin	105444
answer	answer is ministerial correction date of answer 21/01/2022 answer text <p>The vaccine strategy has been delayed due to the Department’s ongoing response to the pandemic. The strategy is being kept under review given the continuously evolving understanding of COVID-19, its vaccines and vaccination programmes and the impact of these developments.</p> answering member constituency Lewes answering member printed Maria Caulfield grouped question UIN 105442 105443 105445 question first answered 21/01/2022 13:05:56 answering member 4492 label Biography information for Maria Caulfield
tabling member	1585 label Biography information for Stephen Hammond

1383106

registered interest
date	29/11/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pneumococcal Diseases: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether the forthcoming vaccination strategy will set a target of 75 per cent for adult pneumococcal vaccination coverage, in line with coverage targets set for influenza vaccination.
tabling member constituency	Ealing, Southall
tabling member printed	Mr Virendra Sharma
uin	83298
answer	answer is ministerial correction date of answer 09/12/2021 answer text <p>The Vaccine Strategy is being kept under review to reflect new developments from the COVID-19 vaccine and extended flu programme. Further detail on content and publication will be available in due course.</p> answering member constituency Lewes answering member printed Maria Caulfield grouped question UIN 83297 83299 question first answered 09/12/2021 14:39:18 answering member 4492 label Biography information for Maria Caulfield previous answer version 36598 answering member constituency Erewash answering member printed Maggie Throup answering member 4447
tabling member	1604 label Biography information for Mr Virendra Sharma

1271365

registered interest
date	15/12/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pneumococcal Diseases: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the availability of the pneumococcal vaccine in (a) Scunthorpe and (b) England.
tabling member constituency	Scunthorpe
tabling member printed	Holly Mumby-Croft
uin	130264
answer	answer is ministerial correction date of answer 22/12/2020 answer text <p>There are two pneumococcal vaccines that are currently recommended for use, pneumococcal polysaccharide 23-valent vaccine (PPV23) and pneumococcal polysaccharide conjugate 13-valent vaccine PCV13 (Prevenar 13).</p><p>We are aware that, due to high demand, supplies of PPV23 are currently out of stock across the country. Further supplies are expected to become available in late January 2021. We are working closely with suppliers and the healthcare system to ensure that patients with the greatest clinical need can access the vaccine. We are continuing to liaise with the supplier to support expedited future deliveries.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 22/12/2020 09:41:18 answering member 4380 label Biography information for Jo Churchill
tabling member	4867 label Biography information for Holly Mumby-Croft

1250421

registered interest
date	10/11/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pneumococcal Diseases: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the availability of the pneumoccal vaccine in (a) Ellesmere Port and Neston and (b) England.
tabling member constituency	Ellesmere Port and Neston
tabling member printed	Justin Madders
uin	113572
answer	answer is ministerial correction date of answer 30/11/2020 answer text <p>There are two pneumococcal vaccines that are currently recommended for use, pneumococcal polysaccharide 23-valent vaccine (PPV23) and pneumococcal polysaccharide conjugate 13-valent vaccine PCV13 (Prevenar 13).</p><p>We are aware that, due to high demand, supplies of pneumococcal vaccine PPV23 (Pneumovax 23) are limited across the country. We are working closely with suppliers and the healthcare system to ensure that patients with the greatest clinical need can access the vaccine. We are continuing to liaise with the supplier to support expedited future deliveries. Public Health England has issued comprehensive clinical guidance which provides information on management of potentially affected patients during this time. Practitioners have been advised to prioritise PPV23 vaccinations based on clinical risk and to plan vaccinations to ensure demand is more consistent across the year. Further, on 6 November 2019, all pneumococcal vaccines were added to the list of medicines that cannot be parallel exported, further protecting United Kingdom supplies and vaccine availability.</p><p>We are not aware of any issue affecting the supply PCV13.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 30/11/2020 12:11:19 answering member 4380 label Biography information for Jo Churchill
tabling member	4418 label Biography information for Justin Madders

1184423

registered interest
date	11/03/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pneumococcal Diseases: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that pharmacies have adequate supplies of the PPV23 vaccine.
tabling member constituency	Streatham
tabling member printed	Bell Ribeiro-Addy
uin	28075
answer	answer is ministerial correction date of answer 19/03/2020 answer text <p>The Department is aware that there is currently limited availability of the pneumococcal polysaccharide vaccine (PPV23). There have been intermittent supply issues over the last 2-3 years due to manufacturing capacity constraints and an increase in global demand for the vaccine.</p><p>Public Health England has issued comprehensive guidance to the National Health Service clinicians on the management of potentially affected patients during this time of limited availability. General Practices have been advised to prioritise PPV23 vaccinations based on clinical risk and to plan vaccinations to ensure demand is more consistent across the year.</p><p>On 6 November 2019, PPV23 was added to the list of medicines that cannot be parallel exported, further protecting United Kingdom supplies and vaccine availability.</p><p> </p><p><strong> </strong></p><p><strong> </strong></p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 19/03/2020 12:24:02 answering member 4380 label Biography information for Jo Churchill
tabling member	4764 label Biography information for Bell Ribeiro-Addy

1177078

registered interest
date	07/02/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pneumococcal Diseases: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to help ensure that the pneumococcal vaccine is available to all people who are eligible.
tabling member constituency	Newton Abbot
tabling member printed	Anne Marie Morris
uin	13990
answer	answer is ministerial correction date of answer 12/02/2020 answer text <p>The Department is aware that there is currently limited availability of the pneumococcal polysaccharide vaccine (PPV23), due to manufacturing capacity constraints. Further deliveries of the vaccines are due at the end of February 2020.</p><p>Public Health England has issued comprehensive guidance to the National Health Service that provides information to clinicians on the management of potentially affected patients during this time of limited availability. General practices have been advised to prioritise PPV23 vaccinations based on clinical risk and to plan vaccinations to ensure demand is more consistent across the year.</p><p>On the 6 November 2019, PPV23 was added to the list of medicines that cannot be parallel exported, further protecting United Kingdom supplies and vaccine availability.</p><p>The vaccine differs from the pneumococcal conjugate vaccine (PCV13) vaccine used for the routine childhood programme. There is no supply issue affecting the PCV13 vaccine used in infants and toddlers—but this vaccine is not suitable for protection of older people.</p><p> </p><p> </p><p> </p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 12/02/2020 17:27:14 answering member 4380 label Biography information for Jo Churchill
tabling member	4249 label Biography information for Anne Marie Morris

1130615

registered interest
date	06/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pneumococcal Diseases: Vaccination
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government, further to the Written Answers by Baroness Blackwood of North Oxford on 22 May (HL15599 and HL15600), whether they will place a copy of the Public Health England modelling on the estimated impact of revising the 13-valent pneumococcal conjugate vaccine schedule from 2+1 to 1+1 in England and Wales, presented at the 37th annual meeting of the European Society for Paediatric Infectious Diseases, in the Library of the House.
tabling member printed	Baroness Masham of Ilton
uin	HL16159
answer	answer is ministerial correction date of answer 18/06/2019 answer text <p>The modelling by Public Health England (PHE) on the estimated impact of revising the pneumococcal conjugate vaccine schedule from 2+1 to 1+1 has been accepted for publication by Public Library of Science (PLoS) Medicine and is due to be published shortly. Release of the modelling data prior to its publication could prejudice publication.</p><p>The poster<em> Estimated impact of revising the 13-valent pneumococal conjugate vaccine schedule from 2+1 to 1+1 in England and Wales: a modelling study,</em> presented by PHE at the European Society for Paediatric Infectious Diseases, provides context for the model on additional invasive pneumococcal disease cases, pneumococcal community acquired pneumonia cases and deaths. A copy of the poster is attached.</p><p>More detail will be available once the published paper is available.</p> answering member printed Baroness Blackwood of North Oxford grouped question UIN HL16160 question first answered 18/06/2019 12:28:36 answering member 4019 label Biography information for Baroness Blackwood of North Oxford attachment 1 file name PHE_poster.pdf title PHE_poster
tabling member	1850 label Biography information for Baroness Masham of Ilton

1130616

registered interest
date	06/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pneumococcal Diseases: Vaccination
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government, further to the Written Answers by Baroness Blackwood of North Oxford on 22 May (HL15599 and HL15600) and the Public Health England modelling on the estimated impact of revising the 13-valent pneumococcal conjugate vaccine schedule from 2+1 to 1+1 in England and Wales, presented at the 37th annual meeting of the European Society for Paediatric Infectious Diseases, how many additional (1) invasive pneumococcal disease cases, (2) pneumococcal community acquired pneumonia cases, and (3) deaths, they predict as a result of a change to a 1+1 vaccine schedule over the next five years.
tabling member printed	Baroness Masham of Ilton
uin	HL16160
answer	answer is ministerial correction date of answer 18/06/2019 answer text <p>The modelling by Public Health England (PHE) on the estimated impact of revising the pneumococcal conjugate vaccine schedule from 2+1 to 1+1 has been accepted for publication by Public Library of Science (PLoS) Medicine and is due to be published shortly. Release of the modelling data prior to its publication could prejudice publication.</p><p>The poster<em> Estimated impact of revising the 13-valent pneumococal conjugate vaccine schedule from 2+1 to 1+1 in England and Wales: a modelling study,</em> presented by PHE at the European Society for Paediatric Infectious Diseases, provides context for the model on additional invasive pneumococcal disease cases, pneumococcal community acquired pneumonia cases and deaths. A copy of the poster is attached.</p><p>More detail will be available once the published paper is available.</p> answering member printed Baroness Blackwood of North Oxford grouped question UIN HL16159 question first answered 18/06/2019 12:28:37 answering member 4019 label Biography information for Baroness Blackwood of North Oxford attachment 1 file name PHE_poster.pdf title PHE_poster
tabling member	1850 label Biography information for Baroness Masham of Ilton